FolioLanternBeta
DGXQuest Diagnostics

Gary Pfeiffer

Director at Quest Diagnostics, as of May 21, 2026Sold $270K of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
31K
shares held after the latest filing, Quest Diagnostics
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1.5K
shares sold, past 12 months
1
days with sales
$270K
largest single day, Oct 22, 2025
1
company filed for

Share of stake sold at Quest Diagnostics is not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $270K no plan disclosed$270KOctNovDecJanFebMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Quest Diagnostics (DGX)DirectorDec 15, 2004May 21, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.